1. AB0492 The Influence of Therapy on CD4+Cd25highfoxp3+ T Regulatory Cells in Systemic Lupus Erythematosus Patients: A Prospective Study. (10th June 2014) Authors: Tselios, K.; Sarantopoulos, A.; Gkougkourelas, I.; Georgiadou, A.-M.; Klonizakis, P.; Kalogeridis, A.; Vlachaki, E.; Boura, P. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 969 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of once‐weekly glucagon‐like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta‐analysis of randomized controlled trials. Issue 11 (23rd September 2015) Authors: Karagiannis, T.; Liakos, A.; Bekiari, E.; Athanasiadou, E.; Paschos, P.; Vasilakou, D.; Mainou, M.; Rika, M.; Boura, P.; Matthews, D. R.; Tsapas, A. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 11(2015:Nov.) Page Start: 1065 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0280 Cd4+cd25highfoxp3+ t regulatory cells as a biomarker of disease activity in systemic lupus erythematosus: a prospective study. (23rd January 2014) Authors: Tselios, K.; Sarantopoulos, A.; Gkougkourelas, I.; Boura, P. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0416 Cd4+Cd25high Foxp3+ T Regulatory Cells and Related Cytokines (IL-6, IL-10, TGF-β) in Neuropsychiatric Systemic Lupus Erythematosus. (10th June 2014) Authors: Tselios, K.; Sarantopoulos, A.; Gkougkourelas, I.; Georgiadou, A.-M.; Pantoura, M.; Psarras, A.; Boura, P. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0497 The Interleukin-1 Inhibitor Canakinumab for Familial Mediterranean Fever: Long-Term Beneficial Effect in A Cohort of 14 Patients. (15th July 2016) Authors: Laskari, K.; Boura, P.; Dalekos, G.N.; Garyfallos, A.; Karokis, D.; Pikazis, D.; Settas, L.; Skarantavos, G.; Tsitsami, E.; Sfikakis, P.P. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Letter: apoptosis and hepatic fibrosis in chronic hepatitis B. Issue 9 (May 2014) Authors: Kountouras, J.; Patsiaoura, K.; Zavos, C.; Chatzopoulos, D.; Katsinelos, P.; Tantsi, N.; Polyzos, S. A.; Giouleme, O.; Gigi, E.; Deretzi, G.; Simeonidou, C.; Grigoriadis, N.; Boura, P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 39:Issue 9(2014) Page Start: 996 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OP0117 Cyclophosphamide Pulse Therapy Leads to T Regulatory Cells Alterations in Active Systemic Lupus Erythematosus. (23rd January 2014) Authors: Tselios, K.; Sarantopoulos, A.; Gkougkourelas, I.; Papagianni, A.; Boura, P. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PO-53 - Prospective evaluation of risk assessment models and biological markers of hypercoagulability for the identification of high VTE risk patients with lung adenocarcinoma. The ROADMAP study. Issue 140 (April 2016) Authors: Boura, P.; Evmorfiadis, I.; Rousseau, A.; Charpidou, A.; Giozos, G.; Van Dreden, P.; Syrigos, K.; Larsen, A.; Elalamy, I.; Gerotziafas, G.T. Journal: Thrombosis research Issue: Issue 140(2016)Supplement 1 Page Start: S196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prevalence of increased arterial stiffness and peripheral arterial disease in patients with systemic lupus erythematosus. (September 2016) Authors: Tziomalos, K.; Gkougkourelas, I.; Sarantopoulos, A.; Bekiari, E.; Makri, E.; Raptis, N.; Tselios, K.; Pantoura, M.; Hatzitolios, A.; Boura, P. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prevalence of increased arterial stiffness and peripheral arterial disease in patients with systemic sclerosis. (September 2016) Authors: Tziomalos, K.; Gkougkourelas, I.; Sarantopoulos, A.; Bekiari, E.; Raptis, N.; Makri, E.; Tselios, K.; Pantoura, M.; Hatzitolios, A.; Boura, P. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗